Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep Learning-based MDixon Quant for Chemotherapy-induced Fatty Liver
NCT06735118Recruiting
- Sponsor
- Yunnan Cancer Hospital
- Start
- Dec 2023
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by Yunnan Cancer Hospital. Primary endpoint: Whole liver fat fraction at 1 year. Started Dec 2023; status: recruiting.
Beyond the preview
Go deeper on NCT06735118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06735118.